Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep 8:3:75.
doi: 10.1186/1743-422X-3-75.

High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions

Affiliations

High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions

Kong T Chong et al. Virol J. .

Abstract

Background: Epithelial defensins including human beta-defensins (hBDs) and alpha-defensins (HDs) are antimicrobial peptides that play important roles in the mucosal defense system. However, the role of defensins in papillomavirus induced epithelial lesions is unknown.

Results: Papilloma tissues were prospectively collected from 15 patients with recurrent respiratory papillomatosis (RRP) and analyzed for defensins and chemokine IL-8 expression by quantitative, reverse-transcriptase polymerase chain reaction (RT-PCR) assays. HBD-1, -2 and -3 mRNAs were detectable in papilloma samples from all RRP patients and the levels were higher than in normal oral mucosal tissues from healthy individuals. Immunohistochemical analysis showed that both hBD-1 and 2 were localized in the upper epithelial layers of papilloma tissues. Expression of hBD-2 and hBD-3 appeared to be correlated as indicated by scatter plot analysis (r = 0.837, p < 0.01) suggesting that they were co-inducible in papillomavirus induced lesions. Unlike hBDs, only low levels of HD5 and HD6 were detectable in papillomas and in oral mucosa.

Conclusion: Human beta-defensins are upregulated in respiratory papillomas. This novel finding suggests that hBDs might contribute to innate and adaptive immune responses targeted against papillomavirus-induced epithelial lesions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
RT-PCR analysis of hBD-1, hBD-2 and hBD-3 mRNA expression in RRP papilloma samples from 15 different individuals ((Left Panel, Lanes 1–15) and normal oral mucosa tissue from 10 different individuals (Right Panel, Lanes 1–10). A housekeeping gene, β-actin (a), was detected as a 450 bp PCR product; hBD-1 (b), hBD-2 (c) and hBD-3 (d) expressions were detected as 108, 172 and 98 bp PCR products, respectively. Samples were separated by 2% agarose gel electrophoresis and stained with ethidium bromide. 100 bp-ladder molecular-weight markers are presented on the left of the panel. Negative controls including amplification without reverse transcriptase or with cDNA sample replaced by DNase, RNase – free, distilled water were performed in each experiment but are not shown due to limited gel space.
Figure 2
Figure 2
hBD-1, hBD-2, hBD-3, HD5, HD6 and IL-8 mRNA expressions were analyzed by real-time RT-PCR. Bars represent defensins expression normalized to β-actin and relative to normal mucosa using the 2-ΔΔCT analysis as described in Materials and Methods. Error bars represent the standard error of the mean of triplicate analysis.
Figure 3
Figure 3
Immunostaining of a representative frozen section of respiratory papilloma with antibody preparations to hBD-1 or hBD-2. Defensins were detectable as strong perinuclear staining of hBD-2 (A) and cytoplasmic immunostaining of hBD-1 (B) in all papilloma sections. Tissue section was counterstained with DAPI (C), and a merged picture was shown in (D). Arrows indicate areas of negative staining for hBD-1 and hBD-2 immunostaining. Tissue sections exposed to antibody preparations derived from preimmune or unrelated immunogens showed no reactivity (data not shown).

Similar articles

Cited by

References

    1. Abrahamson AL, Steinberg BM, Winkler B. Laryngeal papillomatosis: Clinical, histologic and molecular studies. Laryngoscope. 1987;97:678–685. - PubMed
    1. Kahima HK, Mounts P, Shah K. Recurrent respiratory papillomatosis. Obstet Gynecol Clin North Am. 1996;23:699–706. - PubMed
    1. Kimberlin DW. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis. Antiviral Research. 2004;63:141–151. doi: 10.1016/j.antiviral.2004.06.013. - DOI - PubMed
    1. Praetorius F. HPV-associated diseases of oral mucosa. Clin Dermatol. 1997;15:399–413. doi: 10.1016/S0738-081X(96)00157-5. - DOI - PubMed
    1. Bonagura VR, Hatam L, DeVoti JA, Zeng F, Steinberg BM. Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance. Clin Immunol. 1999;93:302–311. doi: 10.1006/clim.1999.4784. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources